⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28871067 | 0.79 | MGAM (0.43) | — | |
| SCHEMBL28761598 | 0.78 | — | — | |
| SCHEMBL9116630 | 0.77 | TSHR (0.53) | — | |
| SCHEMBL29369199 | 0.77 | KDM4E (0.37) | — | |
| SCHEMBL19638975 | 0.76 | — | — | |
| SCHEMBL29225771 | 0.74 | — | — | |
| SCHEMBL3257830 | 0.74 | — | — | |
| SCHEMBL1111039 | 0.74 | — | — | |
| SCHEMBL5146752 | 0.74 | — | — | |
| Monoethanolamine SCHEMBL27989833 | 0.74 | ALDH1A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110381920-A | Peptide for scheroma | 雅利斯塔制药公司 | 2019-10-25 | — | — | CN | disclosed |
| CN-110204478-A | Carbonic anhydrase targeting agent and its application method | 文森医学公司 | 2019-09-06 | — | — | CN | disclosed |
| CN-107254517-A | Disease or the method for illness mark are detected in body fluid | 哈佛大学校长及研究员协会 | 2017-10-17 | — | — | CN | disclosed |
| CN-107119108-A | Disease or the method for illness mark are detected in body fluid | 哈佛大学校长及研究员协会 | 2017-09-01 | — | — | CN | disclosed |
| CN-104411821-B | Recombinant microorganism for the fermentative production of methionine | 代谢探索者公司 | 2017-08-08 | — | — | CN | disclosed |
| CN-104955484-A | Prostate specific antigen agents and methods of using same for prostate cancer imaging | VISEN MEDICAL INC | 2015-09-30 | — | — | CN | disclosed |
| CN-104603289-A | Methods of detecting a disease or condition | STYLLI HARRY | 2015-05-06 | — | — | CN | disclosed |
| CN-104245954-A | Bacterial imaging agents and methods of use thereof | VISEN MEDICAL INC | 2014-12-24 | — | — | CN | disclosed |
| CN-104225613-A | INTEGRIN TARGETING AGENTS AND IN-VIVO AND IN-VITRO IMAGING METHODS USING THE SAME | VISEN MEDICAL INC | 2014-12-24 | — | — | CN | disclosed |
| CN-102026671-B | Integrin targeting agents and in vivo and in vitro imaging methods using the same | VISEN MEDICAL INC | 2014-09-03 | — | — | CN | disclosed |
| CN-102026671-A | Integrin targeting agents and in vivo and in vitro imaging methods using the same | VISEN MEDICAL INC | 2011-04-20 | — | — | CN | disclosed |
| CN-101065131-A | Antimicrobial agents | TECHNION RES & DEV FOUNDATION (IL) | 2007-10-31 | — | — | CN | disclosed |
| CN-1503680-A | Ascorbic a cid analogs for metalloradiopharmaceuticals | ����˹�ж�-����˹˹����ҩƷ��˾ | 2004-06-09 | — | — | CN | disclosed |
| CN-1278819-A | Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating and stress-related | DU PONT PHARM CO (US) | 2001-01-03 | — | — | CN | disclosed |
| CN-1272841-A | Novel lactam metalloprotease inhibitors | DU PONT PHARM CO (US) | 2000-11-08 | — | — | CN | disclosed |
| CN-1268117-A | Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis | DU PONT PHARM CO (US) | 2000-09-27 | — | — | CN | disclosed |
| CN-1251095-A | Lipase capalyzed dynamic resolution of isoxazoline thioester to isoxazoline carboxylic acids | PONT PHARMACEUTICAL CO DU (US) | 2000-04-19 | — | — | CN | disclosed |
| CN-1230184-A | Arylamino fused pyridines and pyrimidines | DU PONT MERCK PHARMA (US) | 1999-09-29 | — | — | CN | disclosed |
| CN-1202161-A | Macrocyclic compounds as metalloproteinase inhibitors | DU PONT MERCK PHARMA (US) | 1998-12-16 | — | — | CN | disclosed |
| CN-1142817-A | 1N-alkyl-N-arylpyrimidinamines and derivatives thereof | DU PONT MERCK PHARMA (US) | 1997-02-12 | — | — | CN | disclosed |